- $3.42bn
- $3.97bn
- $389.29m
- 70
- 16
- 74
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 127 | 161 | 267 | 252 | 389 |
Cost of Revenue | |||||
Gross Profit | 63 | 82.8 | 136 | 106 | 153 |
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 95.8 | 114 | 168 | 181 | 299 |
Operating Profit | 31.3 | 46.7 | 99.3 | 71.3 | 90.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 36.2 | 59.8 | 99.6 | 68.6 | 100 |
Provision for Income Taxes | |||||
Net Income After Taxes | 27.7 | 46.1 | 74.6 | 44.2 | 74.1 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 26.8 | 45.2 | 74.6 | 70.9 | 77.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 26.8 | 45.2 | 74.6 | 70.9 | 77.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.463 | 0.772 | 1.21 | 1.1 | 1.33 |
Dividends per Share |